(Alliance News) - Abingdon Health PLC and Omega Diagnostics Group PLC on Tuesday noted data which showed a rapid Covid-19 test with which they are involved had an accuracy of over 97%.
Rapid tests manufacturer Abingdon and medical diagnostics firm Omega noted an announcement by the UK Rapid Test Consortium about the AbC-19 Covid-19 test, which aims to identify whether a patient has Covid-19-fighting antibodies.
A study performed by scientists at Public Health England and the Universities of Bristol, Warwick and Cambridge assessed four lateral flow rapid virus tests, including AbC-19.
Data showed the AbC-19 was "highly accurate when tested on samples from individuals previously positive for the virus by PCR and from samples collected pre-pandemic".
Omega added: "All devices tested had accuracy of above 92% with the AbC-19 Rapid Test showing the highest accuracy at 97.3%."
Abingdon shares were down 0.5% at 90.55 pence each in London on Tuesday morning. Omega shares were up 4.4% at 83.55p.
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Abingdon Healt. (ABDX)